This paper is only available as a PDF. To read, Please Download here.
Abstract
The concentration of hepatic storage iron (nonheme iron) is increased by 62.3 percent
after portacaval shunting in dogs. Such increase is presumably due to the presence
of an increased amount of hemosiderin, as observed on microscopic examination of sections
of liver. Because of the known reduction of liver volume and the suspected reduction
of hepatic ferritin concentration after shunting, the increase in the concentration
of hepatic storage iron is a reflection of the increase in hepatic hemosiderin concentration.
Hepatic storage iron concentration is not an accurate index of either the increase
in hepatic storage iron content or hepatic hemosiderin content.
The serum iron concentration declines rapidly from 154 γ to 60 γ per 100 ml. after
portacaval shunt and returns slowly to the level prior to operation, while the serum
iron-binding capacity rises slowly from 186 to 238 γ per 100 ml. after portacaval
shunt. The osmotic fragility and half-life of the red cells (Cr51) do not change significantly after portacaval shunt.
The ratio of the rib-marrow space occupied by fat compared to that occupied by hematopoietic
cells is increased from 1:2.3 in dogs undergoing thoracic and orthopedic operations,
to 2.3:1 in dogs undergoing portacaval shunt operations. A selective depression of
erythropoiesis and arrest in red cell maturation do not occur.
These results suggest that hematopoiesis is generally depressed as a result of the
portacaval shunt, and that iron previously used in the production of hemoglobin is
stored in the liver as hemosiderin. The significance of these findings relative to
the reported human cases of hemochromatosis after portal-systemic shunting is discussed.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinical disorders of iron metabolism.Grune & Stratton, Inc, New York1963
- Hemosiderosis and hemochromatosis.in: Wallerstei R.O. Mettier S.R. Iron in clinical medicine. University of California Press, Los Angeles1958: 115-130
- Liver circulation and function.Physiol. Rev. 1963; 43: 115
- Serum iron, serum copper, and total binding capacity of serum in acute hepatitis.Acta. med. scandinav. 1953; 146: 107
- An improved method for the determination of nonhemin iron.J. Biol. Chem. 1940; 135: 23
- Studies on free erythrocyte protoporphyrin, plasma iron, and plasma copper in normal and anemic subjects.Blood. 1948; 3: 501
- Effect of Eck fistula on the dog liver.Arch. Path. 1963; 75: 350
- Plasma iron and iron binding capacity in African males with siderosis.Clin. Sc. 1960; 19: 35
- The effect of inflammation on the utilization of erythrocyte and trans-ferrin-bound radioiron for red cell production.Blood. 1957; 12: 972
- The relationship of hemosiderosis to portacaval shunting.Surgery. 1963; 54: 912
- Ferritin.in: Wallerstein R.O. Mettier S.R. Iron in clinical medicine. University of California Press, Berkeley and Los Angeles1958: 22-42
- Primary biliary cirrhosis: Observations on the natural course of the disease in 25 women.Am. J. Digest. Dis. 1960; 5: 348
- ed. 5. The biology of starvation. Vol. 1. University of Minnesota Press, Minneapolis1950
- Iron transportation.in: Wallerstein R.O. Mettier S.R. Iron in clinical medicine. University of California Press, Los Angeles1958: 8-23
- Iron storage in human disease. Fractionation of hepatic and splenic iron into ferritin and hemosiderin with histochemical correlations.J. Clin. Path. 1963; 16: 101
- Iron metabolism in fractures.Acta. Endocrinol. 1955; 20: 148
- Marrow hyperplasia and hemoglobin reserve in experimental anemia due to bleeding.J. Exper. Med. 1932; 56: 425
- The determination of iron in blood plasma or serum. The determination of the total iron binding capacity of serum.Clin. Chem. Acta. 1957; 2: 214
- The serum iron in experimental hepatocellular necrosis.J. Lab. & Clin. Med. 1954; 43: 572
- The development of hemochromatosis following portacaval anastomosis.Gastroenterology. 1962; 42: 181
- Diseases of the liver.in: J. B. Lippincott Company, Philadelphia and Montreal1963: 655
- Liver disease.Gastroenterology. 1962; 42: 612
- ed. 5. Handbook of biological data. W. B. Saunders Company, Philadelphia and London1956: 172
- Application of the Cr51 technique to the study of experimental hemolysis in the dog.J. Lab. & Clin. Med. 1956; 47: 72
- Parenchymal siderosis in patients with cirrhosis after porta-systemic shunt surgery.New England J. Med. 1961; 265: 928
- Development of hemechromatosis in a patient with Laennec's cirrhosis.Am. J. Med. 1959; 26: 55
- Quantitative measurement of erythropoiesis in the dog.Am. J. Physiol. 1960; 198: 183
- Clinical hematology.ed. 5. Lea & Febiger, Philadelphia1961
Article info
Publication history
Received:
March 24,
1964
Identification
Copyright
© 1965 Published by Elsevier Inc.
